 |
Recombinant human cerebral dopamine neurotrophic factor |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| EU Market Approval | EU |
| EU Designation Date | 2016-04-28 00:00:00 |
| Sponsor | Herantis Pharma Plc |
| |
Recombinant human cerebral dopamine neurotrophic factor |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| EU Market Approval | EU |
| EU Designation Date | 2016-04-28 00:00:00 |
| Sponsor | Herantis Pharma Plc |